UConn Researchers Kill MRSA With Tailored Chemistry

Discussion in 'Alumni stuff' started by Drew, Jan 4, 2017.

  1. Drew

    Drew Its a post, about nothing!

    Joined:
    Jun 19, 2013
    Messages:
    4,327
    Likes Received:
    5,668
    This is pretty cool to read about. Lots of cool things going on at UConn these days:

    UConn Researchers Kill MRSA with Tailored Chemistry - UConn Today

    UConn medicinal chemists have developed experimental antibiotics that kill MRSA, a common and often deadly bacteria that causes skin, lung, and heart infections. The success is due to their strategy, which found a weakness and exploited it in a way the bacteria should have trouble countering, the researchers report in the Dec. 22 issue of Cell Chemical Biology.

    Cases of MRSA (Methicillin-Resistant Staphylococcus aureus) are on the rise and increasingly resistant to common antibiotics. The first choice treatment for MRSA, trimethoprim-sulfamethoxazole, is relatively safe and inexpensive. But trimethoprim-resistant MRSA has begun to spread around the globe. Up to 30 percent of infections in sub-Saharan African no longer respond to it, and significant numbers in Europe and Asia as well.
     
    CAST-BONE likes this.